Regorafenib: Antitumor Activity upon Mono and Combination Therapy in Preclinical Pediatric Malignancy Models.
Daudigeos-Dubus E, Le Dret L, Lanvers-Kaminsky C, Bawa O, Opolon P, Vievard A, Villa I, Pagès M, Bosq J, Vassal G, Zopf D, Geoerger B.
Daudigeos-Dubus E, et al. Among authors: vievard a.
PLoS One. 2015 Nov 23;10(11):e0142612. doi: 10.1371/journal.pone.0142612. eCollection 2015.
PLoS One. 2015.
PMID: 26599335
Free PMC article.